Azithromycin [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-02 17:26 (5869 d 09:43 ago) – Posting: # 5415
Views: 7,476

Hi
The purpose of a BE study is to detect differences in formulations and it is not necessary to reflect clinical use (that's why you can perform the study in population different to the target population). Therefore you can standardise your dose if you have a two way cross-over design. In a parallel design study you should use body weight adjusted dose to reduce inter-subject variability.
Regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
383 visitors (0 registered, 383 guests [including 18 identified bots]).
Forum time: 03:10 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5